CBFa(AML/PEBP2)-related elements in the TGF-β type I receptor promoter and expression with osteoblast differentiation

Journal of Cellular Biochemistry

Volumn 69, Issue 3, 1998, Pages 353-363

  Ji, Changhua ^a   Casinghino, Sandra ^a   Chang, David J ^a   Chen, Yun ^a   Javed, Amjad ^d   Ito, Yoshiaki ^b   Hiebert, Scott W ^c   Lian, Jane B ^d   Stein, Gary S ^d   McCarthy, Thomas L ^a   Centrella, Michael ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

AML CBF PEBP2; CBFa1; Differentiation; Osteoblasts; Receptor; Regulatory elements; Transforming growth factor

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ARTICLE; BONE MINERALIZATION; CELL DIFFERENTIATION; FETUS; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; RAT; REPORTER GENE;

NON-PROGRAMMATIC;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; BINDING SITES; CELL DIFFERENTIATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; NEOPLASM PROTEINS; OSTEOBLASTS; PHENOTYPE; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRANSCRIPTION FACTORS;

EID: 15144361970     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19980601)69:3<353::AID-JCB12>3.0.CO;2-D     Document Type: Article

References (39)

1. Banerjee C, Hiebert SW, Stein JL, Lian JB, Stein GS (1996): An AML-1 consensus sequence binds an osteoblast-specific complex and transcriptionally activates the osteocalcin gene. Proc Natl Acad Sci USA 93:4968-4973.
2. Banerjee C, McCabe LR, Choi J-Y, Hiebert SW, Stein JL, Stein GS, Lian JB (1997): Runt homology domain proteins in osteoblast differentiation: AML3/CBFa1 is a major component of a bone-specific complex. J Cell Biochem 66:1-8.
3. Bradford MM (1976): A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
4. Breen EC, Ignotz RA, McCabe L, Stein JL, Stein GS, Lian JB (1994): TGFβ alters growth and differentiation related gene expression in proliferating osteoblasts in vitro, preventing development of the mature bone phenotype. J Cell Physiol 160:323-335.
5. Calvo MS, Eyre DR, Gundberg CM (1996): Molecular basis and clinical application of biological markers of bone turnover. Endocr Rev 17:333-368.
6. Centrella M, Massague J, Canalis E (1986): Human platelet-derived transforming growth factor beta stimulates parameters of bone growth in fetal rat calvariae. Endocrinology 119:2306-2312.
7. Centrella M, McCarthy TL, Canalis E (1991): Glucocorticoid regulation of transforming growth factor β1 (TGF-β1) activity and binding in osteoblast-enriched cultures from fetal rat bone. Mol Cell Biol 11:4490-4496.
8. Centrella M, Rosen V, Horowitz MC, Wozney JM, McCarthy TL (1995a): Transforming growth factor-β gene family members, their receptors, and bone cell function. In Bikle DD, Negro-Vilar A (eds): "Hormonal Regulation of Bone Mineral Metabolism." Endocr Rev 4:211-226.
9. Centrella M, Casinghino S, Kim J, Pham T, Rosen V, Wozney J, McCarthy TL (1995b): Independent changes in type I and type II receptors for transforming growth factor β induced by bone morphogenetic protein-2 parallel expression of the osteoblast phenotype. Mol Cell Biol 15:3273-3281.
10. Centrella M, Casinghino S, Gundberg C, McCarthy TL, Wozney J, Rosen V (1996a): Changes in bone morphogenetic protein (BMP) sensitivity relative to differentiation in fetal rat bone cell cultures. Ann NY Acad Sci 785:224-226.
11. Centrella M, Ji C, Casinghino S, McCarthy TL (1996b): Rapid flux in transforming growth factor β receptors on bone cells. J Biol Chem 271:18616-18622.
12. Chen R-H, Ebner R, Derynck R (1993): Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-β activities. Science 260:1335-1338.
13. Ducy P, Karsenty G (1995): Two distinct osteoblast-specific cjs-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15:1858-1869.
14. Ducy P, Desbois C, Boyce B, Pinero G, Story B, Dunstan C, Smith E, Bonadio J, Goldstein S, Gundberg C, Bradley A, Karsenty G (1996): Osteocalcin inhibits bone formation in vivo by limiting osteoblast function. Nature 382:448-452.
15. Ducy P, Zhang R, Geoffrey V, Ridall AL, Karsenty G (1997): Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
16. Erlebacher A, Derynck R (1996): Increased expression of TGF-β2 in osteoblasts results in osteoporosis-like phenotype. J Cell Biol 132:195-210.
17. Geoffrey V, Ducy P, Karsenty G (1995): A PEBP2α/AML1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element. J Biol Chem 270:30973-30979.
18. Golling G, Li L-H, Pepling M, Stebbins M, Gergen JP (1996):Drosophila homologs of the proto-oncogene product PEBP2/CBFβ regulate the DNA-binding properties of Runt. Mol Cell Biol 16:932-942.
19. Hagen G, Muller S, Beato M, Suske G (1994): Sp1 mediated transcriptional activation is repressed by Sp3. EMBO J 13:3843-3851.
20. Hiebert SW, Downing JR, Lenny N, Meyers S (1996): Transcriptional regulation by t(8;21) fusion protein, AML1/ ETO. Curr Top Microbiol Immunol 221:253-258.
21. Hock J, Canalis E, Centrella M (1990): Transforming growth factor β (TGFβ-1) stimulates bone matrix apposition and bone cell replication in cultured fetal rat calvariae. Endocrinology 126:421-426.
22. Ito Y, Bae S-C (1997): The Runt domain transcription factor, PEBP2/CBF, and its involvement in human leukemia. In Yaniv M, Ghysdael J (eds): "Oncogenes as Transcriptional Regulators." Vol 2: "Cell Cycle Regulators and Chromosomal Translocation." Basel, Switzerland: Birkhauser Verlag, pp 107-132.
23. Ji C, Casinghino S, McCarthy TL, Centrella M (1996): Cloning, characterization and expression of a rat transforming growth factor-β type I receptor promoter. J Cell Biochem 63:478-492.
24. Ji C, Casinghino S, McCarthy TL, Centrella M (1997): Multiple and essential Sp1 binding sites in the promoter for transforming growth factor-b type I receptor. J Biol Chem 272:21260-21267.
25. Kingsley DM (1994): The TGF-β superfamily: New members, new receptors, and new genetic tests of function in different organisms. Genes Dev 8:133-146.
26. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao Y-H, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T (1997): Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
27. Lee KA, Bindereif A, Green MR (1988): A small-scale procedure for preparation of nuclear extracts that support efficient transcription and pre-mRNA splicing. Gene Anal Technol 5:22-31.
28. Massague J, Attisano L, Wrana JL (1994):The TGF-β family and its composite receptors. Trends Cell Biol 4:172-178.
29. 2 in primary rat osteoblasts. J Biol Chem 271:6666-6671.
30. Merriman HL, van Wijnene AJ, Hiebert S, Bidwell JP, Fey E, Lian J, Stein J, Stein GS (1995): The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/ CBF/runt domain transcription factor family: interactions with the osteocalcin geen promoter. Biochemistry 34:13125-13132.
31. Meyers S, Lenny N, Sun W-H, Hiebert SW (1996): AML-2 is a potential target for transcriptional regulation by the t(8:21) and t(12;21) fusion proteins in acute leukemia. Oncogene 13:303-312.
32. Mundlos S, Otto F, Mundlos C, Mulliken JB, Aylsworth AS, Albright S, Lindhout D, Cole WG, Henn W, Knoll JHM, Owen MJ, Mertelsmann R, Zabel BU, Olsen BR (1997): Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89: 773-779.
33. Ogawa E, Maruyama M, Kagoshima H, Inuzuka M, Lu J, Satake M, Shigesada K, Ito Y (1993): PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc Natl Acad Sci USA 90:6859-6863.
34. Otto F, Thornell AP, Crompton T, Denzel A, Gilmour KC, Rosewell IR, Stamp GWH, Beddington RSP Mundlos S, Olsen BR, Selby PB, Owen MJ (1997): Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89:765-771.
35. Sankar S, Mahooti-Brooks N, Centrella M, McCarthy TL, Madri JA (1995): Expression of transforming growth factor β type III receptor in bovine endothelial cells increases their responsiveness to transforming growth factor β2. J Biol Chem 270:13567-13572.
36. Sankar S, Mahooti-Brooks N, McCarthy TL, Centrella M, Madri, JA (1996): Modulation of transforming growth factor βreceptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 97:1436-1446.
37. Thomas MJ, Umayahara Y, Shu H, Centrella M, Rotwein P, McCarthy TL (1996): Identification of the cAMP response element that controls transcriptional activation of the insulin-like growth factor-I gene by prostaglandin E2 in osteoblasts. J Biol Chem 271:21835-21841.
38. Wieser R, Wrana JL, Massague J (1995): GS domain mutations that constitutively activate TGF-βR-I, the down-stream signaling component in the TGF-β receptor complex. EMBO J 14:2199-2208.
39. Wrana J, Attisano L, Wieser R, Ventura F, Massague J (1994):Mechanism of activation of the TGF-β receptor. Nature 370:341-347.